Safety Study of SGN-CD70A in Cancer Patients

Clinical trial NCT02216890 · COMPLETED

Trial details

NCT number: NCT02216890
Sponsor: Seagen Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Cell Carcinoma Mantle-Cell Lymphoma Diffuse, Large B-Cell, Lymphoma Follicular Lymphoma, Grade 3

Start date: 2014-08-01
Primary completion: 2017-02-15
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.